SLC38A10 has also been found to be associated with Alzheimer’s disease (Hashimoto et al., 2019), and a single-nucleotide polymorphism (SNP) and methylation differences in SLC38A10 have been associated with frontotemporal dementia and schizophrenia (Ferrari et al., 2015; Montano et al., 2016). This evidence concerns the gene SLC38A10 and early-onset autosomal dominant Alzheimer disease.